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Abstract
Hepatocellular carcinoma (HCC) is one the the most fatal cancers worldwide. The poor prognosis of HCC is mainly due to
the developement of distance metastasis. To investigate the mechanism of metastasis in HCC, an orthotopic HCC metastasis
animal model was established. Two sets of primary liver tumor cell lines and corresponding lung metastasis cell lines were
generated. In vitro functional analysis demonstrated that the metastatic cell line had higher invasion and migration ability
when compared with the primary liver tumor cell line. These cell lines were subjected to microRNA (miRNAs) microarray
analysis to identify differentially expressed miRNAs which were associated with the developement of metastasis in vivo.
Fifteen human miRNAs, including miR-106b, were differentially expressed in 2 metastatic cell lines compared with the
primary tumor cell lines. The clinical significance of miR-106b in 99 HCC clinical samples was studied. The results
demonstrated that miR-106b was over-expressed in HCC tumor tissue compared with adjacent non-tumor tissue
(p = 0.0005), and overexpression of miR-106b was signficantly correlated with higher tumor grade (p = 0.018). Further
functional studies demonstrated that miR-106b could promote cell migration and stress fiber formation by over-expressing
RhoGTPases, RhoA and RhoC. In vivo functional studies also showed that over-expression of miR-106b promoted HCC
metastasis. These effects were related to the activation of the epithelial-mesenchymal transition (EMT) process. Our results
suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration
in vitro and metastasis in vivo.
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Introduction
Hepatocellular carcinoma (HCC) is one of the most common
cancers worldwide. It is the third leading cause of cancer deaths
worldwide [1]. The incidence of HCC is particularly high in
Chinese population due to endemic Hepatitis B virus infection [2].
Liver resection and liver transplantation are curative treatments
for early-stage HCC. However, HCC is usually diagnosed at
advanced stage and treatment options for metastatic disease are
very limited. Molecular pathological studies demonstrated that
gene expression alteration is crucial for the development of HCC
metastasis.
MicroRNAs (miRNAs) are small non-coding RNA molecules
which possess regulatory functions for gene expression. Develop-
ment of metastasis is associated with alteration of gene expression,
hence, miRNAs are suspected to be associated with the
development of cancer metastasis. Previous studies have demon-
strated that miRNAs play a critical role in development of cancer
and metastasis. miR-21 and miR-122a can regulate important
tumor suppressors, PTEN and CyclinG1 in HCC [3,4]. MiRNAs
also reported to be associated with metastasis. miR-373 and miR-
520c have been reported to be associated with tumor invasion and
metastasis in breast cancer cell lines [5]. A unique 20-miRNAs
metastasis signature has been identified in HCC clinical samples
[6]. These studies demonstrated miRNAs play a critical role not
only in development of cancer but also in metastasis. miR-106b is
transcripted from the miR-106b-25 cluster located on chromo-
some 7. This miRNA cluster is reported to be over-expressed in
HCC clinical samples [7]. A microarray study demonstrated that
miR-106b was up-regulated in colon cancer with lymph node
metastasis [8]. miR-106b can directly bind to p21 and regulate cell
cycle progression [9]. It can also regulate the E-cadherin
distribution in embryonic lung epithelial branching morphogenesis
through MAPK14 and STAT3 [10]. However the role of miR-
106b in cancer metastasis remains unclear.
Animal models are widely used in cancer research for studying
the development of cancer and metastasis. Microenvironment
affects the development of cancer and metastasis [11]. Orthotopic
PLOS ONE | www.plosone.org 1 March 2013 | Volume 8 | Issue 3 | e57882
animal model can provide a more relevant model of cancer
development in human, and the efficiency for development of
metastasis is higher [12]. This study demonstrated the involvement
of miR-106b in development of HCC metastasis by orthotopic
animal HCC model. Clinicopathological significance of miR-106b
was also evaluated.
Materials and Methods
Cell Lines and Tumor Specimens
HCC cell lines PLC8024, HepG2, Hep3B, Huh7 (ATCC,
Manassas, VA), MHCC97H (obtained from Liver Cancer
Institute, Fudan University, Shanghai, China) [13] and immor-
talized normal hepatocyte cell line MIHA (kind gift from Dr J
Roy-Chowdhury, Albert Einstein College of Medicine) [14] were
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) (Life Technol-
ogies, Carlsbad, CA).
HCC clinical samples were collected with informed written
consent and approval by the Institutional Review Board of the
University of Hong Kong from HCC patients who underwent
hepatectomy in Department of Surgery, Queen Mary Hospital,
University of Hong Kong Medical Center (Hong Kong SAR,
China). Clinicopathological data were collected.
Orthotopic Implantation Tumor Model and
Establishment of Primary and Metastatic Cell Lines
Animal studies were approved by Committee on the Use of Live
Animals in Teaching and Research at the University of Hong
Kong. HCC cell lines, PLC8024 and MHCC97H cells were
labeled with luciferase by lentivirus infection. 56105 cells were
orthotopically implanted into the liver of 4–6 weeks old CB17
SCID mice under anesthesia. Tumor formation was monitored by
IVIS100 in vivo imaging system (Caliper Life Science, Hopkinton,
MA) with intra-peritoneal injection of 3 mg luciferin. After 10–12
weeks of inoculation, mice were sacrificed. Primary liver tumor
and metastatic lung nodules were isolated and subjected to
primary culture. Stable cell lines were checked by luciferase
activity to confirm the cells originated from the parental HCC cell
lines.
Wound-healing Assay and Trans-well Invasion Assay
Cell migration ability was measured by wound-healing assay.
Full confluent cells were seeded into 24-wells plate. Acellular area
was created by scraping using a pipette tip. Wound closure was
measured at 24 and 48 hours interval.
Trans-well invasion assay was performed using matrigel
invasion chamber (BD Biosciences, Bedford, MA). 26105 cells
were seeded into the upper chamber with serum-free DMEM.
DMEM with 10% FBS were put into lower compartment as
chemo-attractant. Cells were allowed to invade for 48 hours.
Remaining cells in the upper chamber were scraped out by cotton
swap. Matrigel membranes were fixed with ice-cold methanol and
stain with 0.1% crystal violet solution. Membranes were then
destained and visualized under microscope. Each experiment were
performed in triplicate and repeated twice.
Stress Fiber Formation Analysis by Phalloidin Staining
Cells were cultured on chamber slide for 24 hours and serum-
starved for another 24 hours. After 48 hours, cells were fixed with
4% paraformaldehyde and cell membranes were permeabilized
with 0.1% TritonX100. Slides were then blocked by 1% BSA, and
FITC-conjugated or TRITC-conjugated phalloidin (Sigma, St
Louis, MO) was hybridized onto the slide at 37uC for 1 hour.
Images were then visualized by fluorescent microscopy.
Total RNA Isolation and miRNA Microarray Analysis
Total RNAs from cell lines and HCC clinical samples were
extracted by Trizol reagent (Life Technologies, Carlsbad, CA)
following manufacture’s protocol.
miRNA microarray analysis was carried out by NCode miRNA
expression profiling service (Life Technologies, Carlsbad, CA).
Total RNAs (10 mg) were enriched by PureLink miRNA isolation
kit (Life Technologies, Carlsbad, CA). Enriched miRNAs were
polyadenylated and subsequently tagged with specific sequences to
enable the detection of fluorescents. Tagged miRNAs were then
purified and hybridized onto NCode Multi-Species miRNA
Microarray V2.0 (Life Technologies, Carlsbad, CA), containing
probes for Sanger mirBASE 9.0, overnight at 52uC. Slides were
then subjected to stringency wash and hybridized to AlexaFluor3
or AlexaFluor5 at 62uC for 4 hours. Slides were then washed and
scan using GenePix4000B microarray scanner (Molecular Device,
Sunnyvale, CA). Data were captured and analyzed by GenePix
Pro software (Molecular Device, Sunnyvale, CA).
First-Strand cDNA Synthesis
First-strand cDNA synthesis for miRNA QPCR analysis was
performed by TaqMan miRNA Reverse Transcription Kit and
MegaPlex Primer Pool (Life Technologies, Carlsbad, CA). Total
RNA (350 ng) was subjected to reverse transcription with
MegaPlex Primer Pool as RT-primer.
QPCR Analysis
TaqMan MicroRNA Assays were used for QPCR analysis.
Reaction mixture containing 1XTaqMan Universal PCR Master
Mix (Life Technologies, Carlsbad, CA), 1XTaqMan MicroRNA
Assay and 1:15 diluted cDNA was subjected to thermal cycling on
7900HT Fast Real-Time PCR System (Life Technologies,
Carlsbad, CA). U6 snRNA was used as reference for the
expression of the mature miRNAs. The cycling conditions were
95uC 10 min, followed by 40 cycles at 95uC 15 sec and 60uC
1 min. Relative miRNAs expression was calculated by 22ddCt
methods.
miRNA Knock-down and Over-expression Functional
Studies
miRNA-106b LNA knock-down probe and the scramble
control (Exiqon, Vedbaek, Denmark) were transfected into the
miR-106b over-expressed cell line, PLC-LM, using Lipofectamine
2000 (Life Technologies, Carlsbad, CA) according to manufac-
turer’s protocol.
Pre-miR-106b was cloned into pCDH-CMV-MCS-EF1-
copGFP vector (System Biosciences, Mountain View, CA).
Pseudoviral particles were prepared by the LentiStarter Kit
(System Biosciences, Mountain View, CA) following the manu-
facturer’s protocol. Pseudoviral particles were used for transduc-
tion in PLC-PT, Huh7, and Hep3B cell lines. One week after
transduction, GFP+ cells were sorted using MoFlow cell sorting
system (Beckman Coulter Inc., Brea, CA). GFP+ cells were
harvested and QPCR analysis was employed to confirm the over-
expression of miR-106b.
Western blotting for RhoGTPases and EMT markers
Protein lysate were obtained from cell lines using RIPA buffer
(Cell Signaling Technology, Danvers, MA). RhoGTPases, RhoA
and RhoC (Cell Signaling Technology, Danvers, MA), and EMT
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markers, E-cadherin, N-cadherin (Cell Signaling Technology,
Danvers, MA), Vimentin (Abcam Inc., Cambridge, MA), and
TWIST1 (Sigma, St Louis, MO), were immune-blotted as
previously described [15].
Statistical Analysis
Statistical analysis was performed by SPSS16.0. Continuous
data and categorical data were analyzed by Student’s t-test and
chi-square test respectively. P-value,0.05 was consider as
statistically significant.
Results
Establishment of Primary and Metastatic Tumor Cell Lines
HCC cell lines PLC8024 and MHCC97H, labeled with
luciferase, were orthotopically implanted into liver of SCID mice
(Fig. 1A). After 10–12, mice were sacrificed and lung metastatic
nodules were discovered in mice (Fig. 1B). Another mouse was
sacrificed for H&E staining to confirm the luciferase signal
originated from the metastatic lung lesions (Fig. 1C). Tumor cells
were isolated for primary culture from both primary liver tumors
and metastatic lung tumors. Stable cell lines derived from
PLC8024 cell line, namely PLC-PT (Primary Tumor) and PLC-
LM (Lung Metastasis), and cell lines from MHCC97H, namely
MHCC97H-PT and MHCC97H-LM, were established. All
derived cell lines show positive luciferase activity, indicating that
all isolated cells originated from the parental luciferase-labeled cell
lines. No observable morphological difference was identified in
these cell lines (Data not shown).
In vitro and in vivo Functional Characterization of the
Primary and Metastatic Cell Lines
Cell proliferation rates of both primary and metastatic cell lines
were analyzed by MTT assay. No obvious differences between
primary tumor and lung metastasis cell lines for both PLC8024
and MHCC97H derived cell lines were observed (Data not
shown).
Migration ability was measured by wound-healing assay. Fig. 2A
shows the wound closure after 24 and 48 hours for PLC-PT and
PLC-LM cell lines. Wound closure was observed in PLC-LM at 24
and 48 hours but not in PLC-PT cell line. Similar experiment was
performed in MHCC97H-PT and MHCC97H-LM cell lines. No
obvious difference between MHCC97H primary and the meta-
static cell lines was observed (Data not shown).
Cell invasion ability was measured by trans-well invasion assay
(Fig. 2B). The invasion ability of PLC-LM was higher than PLC-
PT cell line, and the number of invading cells in PLC-LM was
significantly higher than in PLC-PT (p= 0.01). No obvious
difference was observed in MHCC97H derived cell lines (Data
not shown).
Metastatic ability of the PLC-PT and PLC-LM cell lines were
compared by using the orthotopic animal model (Data not shown).
The PLC-PT cell shows a lower metastatic ability compared to the
parental PLC8024 and PLC-LM after 10 weeks of inoculation.
For the PLC-LM, it has the highest metastatic ability amount
three cell lines and most of the mice develop lung metastasis at
week 10.
Cytoskeleton Rearrangement Promotes Cell Migration
and Cell Invasion
Cytoskeleton structure was visualized by phalloidin staining
(Fig. 2C). PLC-LM cell line had a well-established cytoskeleton
network with stress fiber protruding out from the cell surface.
These features were absent in the PLC-PT cell line.
MicroRNA Microarray Profiling
The primary tumor and lung metastasis cell lines of the two sets
of phenotypically similar cell lines (PLC-PT vs PLC-LM and
MHCC97H-PT vs MHCC97H-LM) were compared by NCode
miRNA microarray profiling service. Array data were deposited at
the Gene Expression Omnibus (GEO accession no.: GSE43445).
MicroRNA candidates were selected by .2-fold difference in
expression with at least 4 out of 6 spots were statistically significant
(p-value,0.001). With criteria mentioned above, 67 miRNAs
candidates were identified from PLC8024 derived cell lines,
whereas 30 candidates were selected from MHCC97H derived cell
lines. Fifteen common candidate human miRNAs were identified
from the microarray analysis from these two sets of cell line
(Table 1).
Quantitative PCR (QPCR) Analysis in HCC Cell Lines and
Clinical Samples
To validate microarray results, PLC8024 and MHCC97H
derived cell lines were subjected to QPCR analysis. miR-106b
expression in other HCC cell lines was also compared. All HCC
cell lines show higher expression of miR-106b than normal
hepatocyte cell line, MIHA (Fig. S1A). Furthermore, two
metastatic cell lines had higher miR-106b expression than the
corresponding primary tumor cell lines (Fig. S1B).
Target miRNAs, which were associated with cell migration
capacity in vitro and metastatic ability in vivo, were identified by
microarray analysis. The clinical relevance of top 8 over-
expressing miRNAs from microarray analysis was first analyzed
Figure 1. Orthotopic HCC metastasis animal model. (A) Primary
liver tumor was detected after 1-week orthotopic implantation using
luciferase labeled HCC cell line, PLC8024. (B) Metastatic nodules were
formed in the lung of the SCID mice at week 10. (C) H&E staining for the
lung of the SCID mice show that luciferin signal from the lung nodules
are orginated from the tumor cells.
doi:10.1371/journal.pone.0057882.g001
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in 20 pairs of matched HCC tumor and non-tumor sample.
Amount these miRNAs, miR-21 and miR-106b show clinical
significance in this 20 HCC clinical sample cohort. This two
miRNA targets were further analyzed by QPCR in another 79
pairs HCC sample (Total 99 pairs). miR-21 and miR-106b
showed significant up-regulation in tumors compared with the
Figure 2. In vitro functional studies for PLC-PT and PLC-LM cell lines. (A) Cell migration ability were compared by wound healing assay.
Wound closure was observed in the PLC-LM but not in the PLC-PT at 24 and 48 hours. (B) Trans-well invasion assay for PLC-PT and PLC-LM. The
number of invading cells in PLC-LM are significantly higher than the PLC-PT (p = 0.01). (C) Phalloidin staining for PLC-PT and PLC-LM. Stress fiber
(white arrow) was observed in PLC-LM but absent in PLC-PT.
doi:10.1371/journal.pone.0057882.g002
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non-tumor tissues (p = 0.0059 and 0.0005 respectively) (Fig. S1C
and S1D). We correlate the expression of the two miRNAs with
clinicopathological data (Table 2). The only significant correlation
observed was higher tumor grade in tumors with miR-106b over-
expression (T vs NT .2-fold) (p = 0.014). There was also a trend
towards advanced TNM stage with miR-106b over-expression,
but the difference was marginally not significant (p = 0.061).
In vitro Functional Studies of miR-106b Konck-down or
Over-expressed Cell Lines
QPCR analysis showed successful miR-106b knock-down in
PLC-LM cells by Locked Nucleic Acid (LNA) with .50%
efficiency from Day 1 to Day 4 after transfection (Fig. S1E), while
the lentiviral system stably over-expressed 9-fold higher miR-106b
than the empty vector control in PLC-PT cells (Fig. S1F). Other 2
HCC cell lines, Huh7 and Hep3B, with lentiviral transduction also
show around 6-fold over-expression of miR-106b compare to the
corresponding vector control (Fig. S1F). MTT assay and trans-well
invasion assay showed that miR-106b expression level affected
neither the cell proliferation rate nor the invasion ability (Data not
shown). However, cell lines with higher miR-106b expression,
PLC-LM/LNA-Scr and PLC-PT/106b+, had higher migration
ability. Fig. 3A and 3B showed the effect on wound healing assay
after miR-106b LNA knock-down in PLC-LM cell line and miR-
106b over-expression in PLC-PT cell line respectively. Since stress
fiber formation can promote cell migration ability, we further
analyzed the stress fiber formation in these cell lines by phalloidin
staining (Fig. 3C and 3D). The results demonstrated that miR-
106b expression can promote formation of stress fiber, hence,
increase migration ability of the HCC cells.
To confirm the functional role of miR-106b in other HCC cell
lines, wound healing assay and phalloidin staining were performed
in other 2 HCC cell lines, Huh7 and Hep3B. The wound healing
assay showed that miR-106b over-expression can enhance the cell
migration ability in vitro in both cell lines (Fig. 4A and 4B). In
addition, the phalloidin staining demonstrated that both cell lines
process more stress fiber in the miR-106b over-expressing cells,
but not in the vector control (Fig. 4C and 4D).
Orthotopic Metastasis Animal Model for PLC-PT with
miR-106b Over-expression
PLC-PT cells stably over-expressing miR-106b were implanted
into liver of SCID mice. Mice were scarified at week 10, lungs
were analyzed by H&E staining (Fig. 3E). Lung metastatic nodules
were observed in 4 out of 5 mice (80%) in the miR-106b over-
expressing group, whereas in the empty vector control group, only
1 out of 5 mice (20%) developed lung metastasis. This result
demonstrated that miR-106b enhanced metastatic capacity of the
PLC-PT cells.
Table 1. Candidate miRNAs identified from miRNA microarray analysis.
Candidate miRNAs Fold-difference by microarray
PLC8024 derived cell lines MHCC97H dervied cell lines
hsa-miR-21 16.53 10.26
hsa-miR-26b 11.94 3.19
hsa-miR-29a 8.72 2.15
hsa-miR-20a 8.38 3.47
hsa-miR-27a 7.23 2.67
hsa-miR-19b 7.06 2.96
hsa-miR-16 6.91 2.55
hsa-miR-106b 6.21 2.63
hsa-miR-106a 5.75 1.98
hsa-let-7a 5.16 2.28
hsa-miR-27b 4.99 3.27
hsa-miR-18a 4.55 2.24
hsa-let-7f 4.06 3.83
hsa-miR-15a 2.86 2.74
hsa-miR-195 2.24 2.00
doi:10.1371/journal.pone.0057882.t001
Table 2. Clinicopathological analysis for miR-21 and miR-
106b expression in HCC clinical samples.
Clinicopathological parameters n p-value
1
(Total = 99) miR-106b miR-21
Sex: Male 81 0.667 0.165
Female 18
Age: ,60 62 0.385 0.770
.=60 37
Tumor Grade: Well/Moderate 70 0.014 0.988
Poor 12
TNM Staging: Stage I/II 36 0.061 0.652
Stage III/IV 62
Microvascular Invasion: +ve 47 0.243 0.890
2ve 51
Tumor Size: ,5 cm 27 0.267 0.553
.=5 cm 71
1Chi-square test.
doi:10.1371/journal.pone.0057882.t002
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Figure 3. In vitro and in vivo studies for miR-106b.miR-106b was over-expressed in PLC-PT and knock-down in PLC-LM cells. (A) Wound-healing
assay for miR-106b knock-down using PLC-LM cells and (B) miR-106b over-expression using PLC-PT cells. Higher miR-106b expressing cells, PLC-LM/
Scr and PLC-PT/106b+, can promote cell migration in vitro. (C) Stress fiber (white arrows) protruding out from cell surface in high miR-106b expressing
cells, PLC-LM/LNA-Scr, but not in the miR-106b knock-down cells, PLC-LM/LNA-106b. (D) Similar founding was observed in miR-106b over-expressing
experiment. (E) H&E staining for in vivo studies showing lung metastatic nodules were present in miR-106b over-expressing cell, PLC-PT/106b+.
doi:10.1371/journal.pone.0057882.g003
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miR-106b Over-expression Up-regulated RhoGTPases
Expression
Expression of RhoGTPases, RhoA and RhoC, were analyzed
by western blot (Fig. 5A). Over-expression of RhoGTPases can be
observed in miR-106b over-expressing cell lines, PLC-LM, PLC-
PT/106b+, PLC-PT/LNA-Scr, PLC-LM/LNA-Scr, Huh7/
106b+, and Hep3B/106b+, but not in the corresponding control.
Our result suggested that miR-106b over-expression can up-
regulate RhoA and RhoC expression.
Regulation of Epithelial-mesenchymal Transition Process
by miR-106b
miR-106b were transiently knocked down by LNA in both
PLC-PT and PLC-LM cell lines. Four EMT markers were
analyzed by western blot. Epithelial marker E-cadherin, mesen-
Figure 4. In vitro functional studies for miR-106b in Huh7 and Hep3B cell lines. Cell migration ability was compared in Huh7 (A) and Hep3B
(B) cell lines with or without over-expression of miR-106b. miR-106b over-expressing cells, Huh7/106b+ and Hep3B/106b+, show enhanced cell
migration ability when compare to its corresponding vector control, Huh7/V.C. and Hep3B/V.C., at 24 and 48 hours interval. Stress fiber formation
was visualized by phalloidin staining (C & D). More stress fiber (white arrow) was observed in miR-106b over-expression cells in Huh7/106b+ (C) and
Hep3B/106b+ (D) cell lines compare to the vector control cell lines, Huh7/V.C. and Hep3B/V.C.
doi:10.1371/journal.pone.0057882.g004
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chymal markers N-cadherin, TWIST1, and Vimentin were
analyzed. Our results demonstrated that upon miR-106b knock-
down, the expression of epithelial marker increased while the
mesenchymal markers decreased (Fig. 5B). This result suggested
that miR-106b over-expression can activate EMT process and
promote cell migration in vitro and metastasis in vivo. Meanwhile,
cells transduced with lentivirus over-expressing miR-106b (PLC-
PT/106b+, Huh7/106b+, Hep3B/106b+) also show activation of
EMT compare to their corresponding vector control (PLC-PT/
V.C., Huh7/V.C., Hep3B/V.C.) (Fig. 5B).
Discussion
HCC is a cancer prone to vascular invasion and metastasis, and
most patients die from metastatic disease. Understanding the
biology of metastasis in HCC is critical to improve patient
prognosis. As primary treatment for metastatic HCC is usually not
by surgery, it is difficult to collect metastatic tumor specimens from
patients. In this study, orthotopic metastasis HCC animal model is
used to study the role of microRNAs in development of metastasis
in HCC.
The primary tumor and lung metastatic cell lines derived from
PLC8024 showed different invasiveness in vitro. The PLC-LM cell
line was highly invasive and had higher migration ability.
However, the proliferation rates are similar in PLC-PT and
PLC-LM cell line. This suggested that metastasis development in
vivo is related to enhanced cell migration and invasion ability
rather than cell proliferation. In contrast, we did not observe
higher migration capacity in MHCC97H-LM when compared to
the MHCC97H-PT cell line. This may be due to the facts that
MHCC97H is already a highly metastatic cell line, some of the
molecular pathways involved in promoting the aggressive pheno-
type are deregulated, so the difference between MHCC97H-LM
and MHCC97H-PT were not obvious. Even we can observed
miR-106b expression is higher in MHCC97H-LM, this does not
make any differences in the in vitro functional characteristics of this
two cell lines since some of the down-stream molecule are
deregulated due to the aggressive nature in the parental cell line,
MHCC97H.
To explore the role of miRNAs in development of metastasis,
two metastatic cell lines derived from PLC8024 and MHCC97H
were compared with the corresponding primary tumor cell lines by
microarray analysis. More miRNAs were differentially expressed
in the PLC8024 derived cell lines. These genotypic differences
may contribute to the phenotypic differences in vitro between the
primary tumor and lung metastasis cell lines. The metastatic cell
Figure 5. Alteration of RhoGTPases and EMTmarkers expression attributed to miR-106b expression. (A) High miR-106b expressing cells
(PLC-LM, PLC-PT/106b+, PLC-PT/LNA-Scr, PLC-LM/LNA-Scr, Huh7/106b+, and Hep3B/106b+) show over-expression of RhoA and RhoC by western
blotting. (B) Expression of EMT markers, E-cadherin, N-cadherin, Vimentin, and TWIST1, were analyzed by western blot. PLC-LM shows higher
expression of N-cadherin, Vimentin, and TWIST1, but less E-cadherin, indicating EMT process is activated in the metastatic cell line. miR-106b knock-
down cells decrease mesenchymal markers expression and increase epithelial marker expression indicating miR-106b expression can activate EMT
process. N-cadherin and TWIST1 expression are too low to be detected in PLC-PT. EMT activation was also observed in miR-106b over-expressing cell
lines, Huh7/106b+ and Hep3b/106b+, but not in its corresponding vector control.
doi:10.1371/journal.pone.0057882.g005
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line showed higher migration and invasion abilities than the
primary tumor cell line in PLC8024 derived cell lines, but not in
the MHCC97H derived cell lines. However, metastatic ability in
vivo was similar between PLC8024 and MHCC97H cell lines and
those commonly differential expressed miRNAs maybe related to
the development of metastasis. By comparing miRNA microarray
profile of the PLC8024 and MHCC97H derived cell lines, 15
human miRNAs were differentially expressed in primary tumor
cell lines versus the metastatic cell lines. Although our focus in this
study was miR-106b, the highest differentially expressed miRNA
was miR-21, which is a well-known miRNA involved in various
kinds of cancer including HCC [3,16,17] and has been proven to
promote metastasis in breast and colorectal cancer [18,19]. In
contrast, miR-106b is a new candidate miRNA with potential
importance in HCC metastasis for further in vitro and in vivo
studies.
QPCR analysis for miR-21 and miR-106b expression in HCC
and nontumorous liver was performed. U6 was chosen as the
reference in our studies as it is stably expressed in all cell lines and
clinical sample cohort. Several studies have demonstrated the
critical role of miR-21 in HCC carcinogenesis [3,16,20,21] and
our orthotopic model confirmed its functional role in HCC
progression. We further confirm the clinical significance of miR-21
by showing its over-expression in HCC tumor. We also analyzed
the clinical relevance of miR-106b expression. Our results
demonstrated that miR-106b was over-expressed in tumor tissue
compared with the adjacent non-tumor tissue. We correlated
clinicopathological parameters of the patients with miR-106b
expression and observed that over-expression of miR-106b (.2-
fold difference between tumor and non-tumor) correlated with
higher tumor grade, which is associated with more aggressive
disease and poor prognosis. Moreover, there was higher expression
of miR-106b in more advanced tumor stage, although the
difference was marginally not significant.
To investigate the functional role of miR-106b, we knocked
down miR-106b in the lung metastasis cell line with high miR-
106b expression and over-expressed miR-106b in the primary
tumor cell lines with low miR-106b expression. LNA knock-down
in vitro were transient and .50% knock-down could be attained
within 4 days post-transfection. We performed a series of
experiments including MTT assay, migration and invasion assay
to study the functions of miR-106b. Our results suggested that
migration ability decreased upon miR-106b knock-down without
affecting cell proliferation rate and invasion ability, suggesting the
main functional role of miR-106b in enhancing cell motility. To
confirm this finding, we also over-expressed miR-106b in PLC-PT
cell line. Migration ability was increased when we over-expressed
miR-106b in the cells without affecting cell proliferation rate and
invasion ability. Since miR-106b could increase cell migration
ability in PLC-PT cell lines, we visualized the stress fiber
formation, which can promote cell migration, by phalloidin
staining. In order to confirm our finding in other HCC cell lines,
we perform both wound healing assay and phalloidin staining in
Huh7 and Hep3B cell lines. We observed higher cell migration
ability with increase in stress fiber formation upon miR-106b over-
expression. We demonstrated that over-expression of miR-106b
can increase stress fiber formation, hence, enhancing migration
ability in vitro.
PLC-PT cell line with stable over-expression of miR-106b was
orthotopically implanted into the mice to examine the in vivo
metastatic potential. We observed lung metastatic nodules in 80%
of mice inoculated with miR-106b over-expressing cells, whereas
only 20% mice developed lung metastasis in the empty vector
control group. This showed that miR-106b expression could
promote formation of lung metastatic nodules in mice, further
corroborating a critical role of miR-106b in development of HCC
metastasis.
RhoGTPases, RhoA and RhoC, are reported to be involved in
regulation of actin polymerization and organization of actin
cytoskeleton resulting in stress fiber formation [22]. Our in vitro
studies demonstrated miR-106b over-expression can increase
cancer cell motility by inducing stress fiber formation. Since
RhoA and RhoC are essential RhoGTPases involved in stress fiber
formation and cell migration, expression level of RhoA and RhoC
were analyzed. Our results demonstrated that miR-106b over-
expressing cells, PLC-LM, have higher expression level for RhoA
and RhoC than the PLC-PT. Knock-down of miR-106b
significantly down-regulate RhoA and RhoC expression, but not
in the scramble control. This indicated that expression of miR-
106b can indirectly regulate the expression of RhoGTPases. This
observation can be confirmed by up-regulation of RhoGTPases in
miR-106b over-expressing transfectant, PLC-PT/106b+, Huh7/
106b+, and Hep3b/106b+. Up-regulation of RhoA and RhoC are
essential for cell migration and cancer metastasis in various
cancers [23]. Our result suggested that increase of cell motility in
vitro and metastasis development in vivo were affected by the
indirect regulation of RhoA and RhoC through miR-106b
regulation.
Previous studies have already demonstrated that miR-106b was
involved in various important signaling pathways such as PTEN
tumor-suppressive pathway [24], and TGF-beta signaling pathway
[25]. It is also involved in cell cycle progression through p21 [26]
and RB [27]. We postulated that miR-106b over-expression may
regulate EMT process in cancer. Our in vitro and in vivo data
supported this hypothesis. With higher miR-106b expression, the
cells exhibited higher metastatic potential. When miR-106b
expression was down-regulated, expression of epithelial marker,
E-cadherin, increased while mesenchymal markers, N-cadherin,
Vimentin, and TWIST1, decreased. Taken together, our data
suggest a role of miR-106b in metastasis of HCC via activation of
EMT process and enhancement of cell motility. This is the first
study reporting the role of miR-106b in HCC metastasis and
implies a potential strategy to inhibit metastasis in HCC by
targeting miR-106b.
Supporting Information
Figure S1 QPCR analysis in cell lines and clinical
sample. (A) miR-106b expression in HCC cell lines is higher
than immortalized normal hepatocyte cell line MIHA. (B) Higher
miR-106b expression was observed in metastatic cell lines than the
primary tumor cell lines. (C) miR-21 and (D) miR-106b expression
were analyzed in HCC clinical sample by QPCR. Expression of
miR-21 and miR-106b was significantly higher in HCC tumor
tissue. (E) Successful knock-down of miR-106b expression was
attained within 4 days after transfection. (F) Over-expression of
miR-106b in PLC-PT, Huh7 and Hep3B cell lines can be attained
by lentiviral transduction by comparing with the empty vector
control.
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